Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Xilio Therapeutics, Inc.Listing on record | Sell | $464.8 | SEC | ||
Xilio Therapeutics, Inc.Listing on record | Sell | $495 | SEC | ||
Xilio Therapeutics, Inc.Listing on record | Sell | $1.3K | SEC | ||
Xilio Therapeutics, Inc.Listing on record | Sell | $1.4K | SEC | ||
Disc Medicine, Inc.Listing on record | Sell | $1.3M | SEC | ||
Disc Medicine, Inc.Listing on record | Sell | $1.9M | SEC | ||
Disc Medicine, Inc.Listing on record | Sell | $5.2M | Unusual size | SEC | |
Disc Medicine, Inc.Listing on record | Sell | $3.9M | Unusual size | SEC | |
Disc Medicine, Inc.Listing on record | Sell | $5.8M | SEC | ||
Disc Medicine, Inc.Listing on record | Sell | $109.6K | SEC | ||
Disc Medicine, Inc.Listing on record | Sell | $3.8M | SEC | ||
Kymera Therapeutics, Inc.Listing on record | Sell | $632.6K | SEC | ||
Kymera Therapeutics, Inc.Listing on record | Sell | $811.7K | SEC | ||
Kymera Therapeutics, Inc.Listing on record | Sell | $2.9M | SEC | ||
Kymera Therapeutics, Inc.Listing on record | Sell | $2.3M | SEC |